Mid-Day Market Update: Gold Rises 1%; Deciphera Pharmaceuticals Shares Plummet
Today, 4:41 PM
Midway through trading Friday, the Dow traded up 0.65% to 36,358.13 while the NASDAQ rose 0.48% to 16,016.51. The S&P also rose, gaining 0.58% to 4,707.33.
64 Stocks Moving In Friday’s Mid-Day Session
Today, 4:41 PM
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.
The Daily Biotech Pulse: NRx’s Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Today, 4:41 PM
Here's a roundup of top developments in the biotech space over the last 24 hours.
Emergent BioSolutions Q3 EPS $(0.36) Down From $2.19 YoY, Sales $329.00M Miss $486.84M Estimate
Today, 4:41 PM
Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.36) per share. This is a 116.44 percent decrease over earnings of $2.19 per share from the same period last year. The company reported quarterly sales of
Earnings Scheduled For November 4, 2021
Today, 4:41 PM
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Today, 4:41 PM
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Millions Of JNJ COVID-19 Shots Sit Idle At Emergent’s Baltimore Plant: Reuters
Today, 4:41 PM
Around 30 million to 50 million doses of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine manufactured earlier this year sit idle in Emergent BioSolutions Inc's (NYSE: EBS) Baltimore plant,&nbs
The Daily Biotech Pulse: Moderna’s Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO
Today, 4:41 PM
Here's a roundup of top developments in the biotech space over the last 24 hours.